Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neoplasms of the CNS

Free Subscription 08.12.2025 1 AJNR Am J Neuroradiol 4 BMC Cancer 1 BMC Neurol 2 Cancer 3 Childs Nerv Syst 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 3 J Neurooncol 1 J Neuropathol Exp Neurol 2 Neuro Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. IVANIDZE J, Vu KV, Fu R, Brandmaier A, et al
   Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma.
   AJNR Am J Neuroradiol. 2025 Dec 1:ajnr.A9120. doi: 10.3174/ajnr.A9120.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. HUSEYINOGLU Z, Uysal E, Inan MA, Demirci T, et al
   Optimal qMSP cutoff value for MGMT promoter methylation in glioblastoma and its validation for clinical significance.
   BMC Cancer. 2025;25:1833.
   PubMed         Abstract available
   
   
3. ZHANG H, Gao M, Gao Z, Yao L, et al
   Identification and validation of SUN modification-related anti-PD-1 immunotherapy-resistance signatures to predict prognosis and immune microenvironment status in glioblastoma.
   BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15345.
   PubMed         Abstract available
   
   
4. FLETCHER EV, Shard C, Boyle Y, Milligan CJ, et al
   Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment.
   BMC Cancer. 2025 Dec 2. doi: 10.1186/s12885-025-15319.
   PubMed        
   
   
5. SARFRAZ Z, Ozair A, Bardhan M, Starosciak AK, et al
   Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial.
   BMC Cancer. 2025 Dec 4. doi: 10.1186/s12885-025-15224.
   PubMed         Abstract available
   
   

   
   BMC Neurol

6. CHEN CY, Liao WC, Jan CI
   Cervical dumbbell meningioma exhibiting distinct histopathological subtypes in intradural and extradural components: a case report.
   BMC Neurol. 2025 Dec 2. doi: 10.1186/s12883-025-04550.
   PubMed        
   
   

   
   Cancer

7. ZHANG J, Wang P, Ren Y, Chen L, et al
   Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial.
   Cancer. 2025;131:e70171.
   PubMed         Abstract available
   
   
8. TENG H, Yu J, Pang Y, Yan O, et al
   Long-term recurrence risk and temporal dynamics after resection of intracranial meningiomas: A multicenter cohort study with up to 15 years of follow-up.
   Cancer. 2025;131:e70200.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

9. KALYAL N, Vasilica AM, Tambirajoo K, King A, et al
   Burr hole monoportal endoscopic resection of a large choroid plexus cyst causing obstructive hydrocephalus: diagnosis, management and literature review.
   Childs Nerv Syst. 2025;41:400.
   PubMed         Abstract available
   
   
10. KAMEDA-SMITH MM, Lannon M, Almojuela A, MacLean MA, et al
    National multicentered retrospective review of salvage therapy for pediatric medulloblastoma: a Canadian experience.
    Childs Nerv Syst. 2025;41:391.
    PubMed         Abstract available
    
    
11. FROME S, Dastagirzada Y, Kurland D, Wisoff J, et al
    Mapping the evolution of pediatric craniopharyngioma research: a bibliometric analysis.
    Childs Nerv Syst. 2025;41:389.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. VAN DEN ENDE B, de Smet F, Jacobs S, Coosemans A, et al
    Advances in preclinical models for pediatric diffuse intrinsic pontine glioma.
    Int J Cancer. 2025 Nov 30. doi: 10.1002/ijc.70275.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

13. ZHAO J, Vaios E, Calabrese E, Yang Z, et al
    An Explainable Deep Model for Risk Scoring and Accurate Radionecrosis Identification Following Brain Metastasis Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2025 Nov 27:S0360-3016(25)06522.
    PubMed         Abstract available
    
    

    
    J Neurooncol

14. RYBA A, Mohme T, Kerschbaumer J, von Bronewski E, et al
    Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma.
    J Neurooncol. 2025;176:102.
    PubMed         Abstract available
    
    
15. SBAIH O, Singh A, Li A, Kolady R, et al
    Factors affecting postoperative seizure risk and perioperative outcomes in pediatric brain tumor resections.
    J Neurooncol. 2025;176:105.
    PubMed        
    
    
16. ROCHE J, Guerra A, Remaud J, Liger C, et al
    Disruption of cognitive flexibility and planning skills after childhood brain tumor treatment: clinical issues and comprehensive assessment.
    J Neurooncol. 2025;176:104.
    PubMed        
    
    

    
    J Neuropathol Exp Neurol

17. BELAKHOUA S, Lopez G, Dubey S, Rai S, et al
    RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implications.
    J Neuropathol Exp Neurol. 2025 Nov 29:nlaf129. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

18. JIANG S, Xu H, Sun M, Xu Y, et al
    IL-8-Induced Tumor Self-Rampart Spatially Confines Oncolytic Virotherapy in Glioblastoma.
    Neuro Oncol. 2025 Dec 3:noaf276. doi: 10.1093.
    PubMed         Abstract available
    
    
19. AVERY RA
    Including Visual Outcomes in Optic Pathway Glioma Clinical Trials.
    Neuro Oncol. 2025 Dec 1:noaf272. doi: 10.1093.
    PubMed        
    
    

    
    PLoS One

20. 
    Expression of Concern: Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1.
    PLoS One. 2025;20:e0337964.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.